Lynch DR - Search Results

1

Pharmacological therapeutics in Friedreich ataxia: the present state.

Strawser C, Schadt K, Hauser L, McCormick A, Wells M, Larkindale J, Lin H, Lynch DR. Strawser C, et al. Among authors: lynch dr. Expert Rev Neurother. 2017 Sep;17(9):895-907. doi: 10.1080/14737175.2017.1356721. Epub 2017 Jul 26. Expert Rev Neurother. 2017. PMID: 28724340 Review.

2

Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia.

Wilson RB, Lynch DR, Fischbeck KH. Wilson RB, et al. Among authors: lynch dr. Ann Neurol. 1998 Jul;44(1):132-4. doi: 10.1002/ana.410440121. Ann Neurol. 1998. PMID: 9667602

3

Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features.

McCormack ML, Guttmann RP, Schumann M, Farmer JM, Stolle CA, Campuzano V, Koenig M, Lynch DR. McCormack ML, et al. Among authors: lynch dr. J Neurol Neurosurg Psychiatry. 2000 May;68(5):661-4. doi: 10.1136/jnnp.68.5.661. J Neurol Neurosurg Psychiatry. 2000. PMID: 10766903 Free PMC article.

4

Increased serum transferrin receptor concentrations in Friedreich ataxia.

Wilson RB, Lynch DR, Farmer JM, Brooks DG, Fischbeck KH. Wilson RB, et al. Among authors: lynch dr. Ann Neurol. 2000 May;47(5):659-61. Ann Neurol. 2000. PMID: 10805340

5

Near infrared muscle spectroscopy in patients with Friedreich's ataxia.

Lynch DR, Lech G, Farmer JM, Balcer LJ, Bank W, Chance B, Wilson RB. Lynch DR, et al. Muscle Nerve. 2002 May;25(5):664-673. doi: 10.1002/mus.10077. Muscle Nerve. 2002. PMID: 11994959

6

Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.

Lynch DR, Farmer JM, Balcer LJ, Wilson RB. Lynch DR, et al. Arch Neurol. 2002 May;59(5):743-7. doi: 10.1001/archneur.59.5.743. Arch Neurol. 2002. PMID: 12020255 Review.

7

Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia.

Lynch DR, Farmer JM, Rochestie D, Balcer LJ. Lynch DR, et al. J Neuroophthalmol. 2002 Dec;22(4):270-4. doi: 10.1097/00041327-200212000-00003. J Neuroophthalmol. 2002. PMID: 12464730

8

Performance measures in Friedreich ataxia: potential utility as clinical outcome tools.

Lynch DR, Farmer JM, Wilson RL, Balcer LJ. Lynch DR, et al. Mov Disord. 2005 Jul;20(7):777-82. doi: 10.1002/mds.20449. Mov Disord. 2005. PMID: 15747359

9

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ. Lynch DR, et al. Neurology. 2006 Jun 13;66(11):1711-6. doi: 10.1212/01.wnl.0000218155.46739.90. Neurology. 2006. PMID: 16769945 Clinical Trial.

10

Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H. Babady NE, et al. Among authors: lynch dr. Mol Genet Metab. 2007 Sep-Oct;92(1-2):23-35. doi: 10.1016/j.ymgme.2007.05.009. Epub 2007 Jun 26. Mol Genet Metab. 2007. PMID: 17596984 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters